Dr. Bo Xuan earned her MD with honors from Nanjing Medical University (NMU) in 1984. She served on the faculty at the Department of Pharmacology at NMU from 1984 to 1996 before being recruited to the Institute of Ocular Pharmacology (IOP). Xuan advanced rapidly from research associate to assistant research professor in 1999. During her tenure at the IOP, she has published 20 papers and has successfully converted to clinician in 2003. Her research accomplishments in ocular pharmacology and therapeutics include, but are not limited to, the treatment of glaucoma, age related macular degeneration (AMD), cataracts, ischemic retinopathy, dry eye syndrome, uveitis and myopia. Further, she has participated in the clinical project of systemic delivery of glucagon to diabetic patients through the eyes. Currently she works as a physician in the Student Health Services of Texas A&M University and as a clinical assistant professor of IOP in the Texas A&M College of Medicine.

Representative publications

  1. Xuan, B., McClellan, D.A., Moore, R., Chiou, G.C.Y. (2005). Alternative delivery of insulin via eye drops. Diabetes Technology & Therapeutics. 7(5): 695-698.
  2. Xuan, B., Chiou G.C.Y. (2003). Release of nitric oxide by N-nitropyrazoles in rabbit lacrimal gland cell culture. J. Ocular Pharmacol. Ther. 19: 265-270.
  3. Xuan, B., Xu, XR, Chiou, G.C.Y., Zhang, YH, PengcSX (2003). Relationship between nitric oxide production and choroidal blood flow.'^. Ocular Pharmacol.Ther. 19: 247-253.
  4. Xuan. B., T. Wang, Chiou, G.C.Y., I. Dalinger, T.K. Shkineva, and S.A. Sevelev. (2001). Effects of N-Nitropyrazoles on the ocular blood flow of rabbits and retinalfunction of recovery of rat eyes after ischemic insults. J. Ocular Pharmacol.Ther. 17: 505-515.
  5. Chiou, G.C.Y., Xuan, B., Liu, Q,. Yarnasaki, T. and Okawara, T. (2000). Inhibition of Interleukin-1-induced uveitis and corneal fibroblast proliferation byinterluekin-1 blockers. J. Ocular Pharmacol. Ther. 16: 407-418.
  6. Liu, Q., Zhou, Y.H., Xuan. B., Chiou, G.C.Y. and Okawara, T. (2000). Effects of interleukin-1 blockers on corneal fibroblast proliferation in vitro and ocularinflammation in vivo. J. Ocular P.h.a rmacol. Ther. 16: 81-96.